<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        142-172-03
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2003
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        ROLAN 25 mg/ml solution for injection
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        RANITIDINE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        25
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution for injection
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        2
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Ampoule
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        17.7
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Hikma Farmaceutica" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Hikma Farmaceutica
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 612]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Abdulrehman Algosaibi G.T.C.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Hikma Pharmaceuticals PLC
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        A02BA02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>ROLAN contains a medicine called ranitidine.<br />This belongs to a group of medicines called H2-receptor antagonists. It lowers&nbsp;the amount of acid in your stomach.<br />For adults (including the elderly) ROLAN is used to:</p><ul><li>Heal and stop ulcers in the stomach, or the part of the gut it empties into (the duodenum).</li><li>Stop ulcers from bleeding.</li><li>Improve problems caused by acid in the food, pipe (oesophagus) or too much acid in the stomach. Both of these can cause pain or discomfort sometimes known as &lsquo;indigestion&rsquo;, &lsquo;dyspepsia&rsquo; or &lsquo;heat burn&rsquo;.</li><li>Stop acid coming up from the stomach while under anaesthetic during an operation.</li></ul><p>For children (6 months to 18 years) ROLAN is used to:</p><ul><li>Heal ulcers in the stomach, or the part of the gut it empties into (the duodenum).</li><li>Heal and stop problems caused by acid in the food pipe (oesophagus) or&nbsp;too much acid in the stomach. Both of these can cause pain or discomfort&nbsp;sometimes known as &ldquo;indigestion&rdquo;, &ldquo;dyspepsia&rdquo; or &ldquo;heartburn&rdquo;.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not have ROLAN if:</strong></p><ul><li>You are allergic (hypersensitive) to ranitidine or any of the other ingredients of ROLAN.</li></ul><p>If you are not sure, talk to your doctor or pharmacist before having ROLAN.</p><p><strong>Take special care with ROLAN</strong><br />Check with your doctor or pharmacist before having your medicine if:</p><ul><li>You have stomach cancer.</li><li>You have kidney problems. You will need to have a different amount of&nbsp;ROLAN.</li><li>You have had stomach ulcers before.</li><li>You have a history of heart trouble.</li><li>You have a rare condition called acute porphyria.</li><li>You are over 65 years old.</li><li>You have lung disease.</li><li>You are diabetic.</li><li>You have any problems with your immune system.</li></ul><p>If you are not sure if any of the above applies to you, talk to your doctor or&nbsp;pharmacist before having this medicine.<br /><strong>Taking other medicines, herbal or dietary supplements&nbsp;</strong><br />Please tell your doctor or pharmacist if you are taking or have recently taken&nbsp;any other medicines. This includes medicines that you buy without a prescription&nbsp;and herbal medicines. This is because ROLAN can affect the way some other medicines work. Also some other medicines can affect the way ROLAN works.<br />In particular tell your doctor or pharmacist if you are taking any of the following medicines:</p><ul><li>Lidocaine, a local anaesthetic.</li><li>Propranolol, procainamide or n-acetylprocainamide, for heart problems.</li><li>Diazepam, for worry or anxiety problems.</li><li>Phenytoin, for epilepsy.</li><li>Theophylline, for breathing problems (asthma).</li><li>Warfarin, for thinning your blood.</li><li>Glipizide, for lowering blood glucose.</li><li>Atazanavir or delaviridine, for treating HIV infection.</li><li>Triazolam, for insomnia.</li><li>Gefitnib, for lung cancer.</li><li>Ketoconazole, an anti-fungal medicine, sometimes used for treating thrush.</li></ul><p>Midazolam is a medicine that may be given to you just before you have an&nbsp;operation. Tell the doctor you are taking ROLAN before your operation in case he or she wants to give you midazolam.<br />If you are not sure if any of the above applies to you, talk to your doctor or&nbsp;pharmacist before having ROLAN.<br /><strong>Pregnancy and breast feeding</strong><br />If you are pregnant, might become pregnant or are breast-feeding, you should&nbsp;not take this medicine unless your doctor advises it is essential.<br />Ask your doctor or pharmacist for advice before taking any medicine, if you are pregnant or breast-feeding.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>You will never be expected to give yourself this medicine. It will always be given&nbsp;to you by a person who is trained to do so.<br />ROLAN ampoule will be given to you either:</p><ul><li>As a single injection into a muscle.</li><li>As a slow infusion into a vein. This is where the drug is slowly given to you over a few minutes.</li><li>As a continuous infusion into a vein. This is where the drug is slowly given to you over a few hours.</li></ul><p>The usual dose for an adult (including the elderly) and adolescents (12 years and older) is 50 mg every 6 to 8 hours, as a single injection into a muscle.<br />Different doses may also be given to you as a slow infusion or continuous&nbsp;infusion, depending on what condition you are being treated for.<br />Children and infants (6 months to 11 years):<br />Your doctor will give ROLAN by a slow injection into a vein. The maximum dose is 50 mg every 6 or 8 hours. It is usually only given while your child is unable to&nbsp;take ROLAN by mouth.<br /><strong>If you take more ROLAN than you should</strong><br />Your doctor or nurse will give you ROLAN ampoule so it is unlikely that you will&nbsp;receive too much. If you think you have been given too much or have missed a&nbsp;dose, tell your doctor or nurse.<br /><strong>If you forget to take ROLAN</strong><br />It is unlikely as ROLAN is given to you by your doctor or healthcare provider. But&nbsp;if you are concerned about missing a dose, speak to your doctor or healthcare&nbsp;provider.&nbsp;</p><p>If you have any further questions on the use of this product, ask your doctor,&nbsp;healthcare provider or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, ROLAN can cause side effects, although not everybody gets them.<br />The following side effects may happen with this medicine.<br />Stop taking ROLAN and see a doctor straight away, if you notice any of the&nbsp;following serious side effects, you may need urgent medical treatment:</p><ul><li>allergic reactions, the signs may include:</li></ul><p>- Rash, itching or hives on the skin.</p><p>- Swelling of your face, lips, tongue or other parts of the body.</p><p>- Chest pain, shortness of breath, wheezing or having trouble breathing.</p><p>- Unexplained fever and feeling faint, especially when standing up.</p><ul><li>Kidney problems, which can lead to back pain, fever, pain when passing urine, blood in the urine and changes in blood tests.</li><li>Severe stomach pain, this may be a sign of something called &lsquo;pancreatitis&rsquo;.</li><li>A slow or irregular heartbeat.</li></ul><p>Check with your doctor at your next visit if you notice any of the following:<br /><strong>Uncommon </strong>(affects less than 1 in 100 people)</p><ul><li>Stomach pain.</li><li>Constipation.</li><li>Feeling sick (nausea).</li></ul><p><strong>Rare</strong> (affects up to 1 in 1,000 people)</p><ul><li>Skin rash.</li></ul><p><strong>Rare side effects that may show up in blood tests:</strong></p><ul><li>Increase of serum creatinine in the blood (kidney function test).</li><li>Changes to liver function.</li></ul><p>Check with your doctor as soon as possible if you notice any of the following:<br /><strong>Very rare</strong> (affect less than 1 in 10,000 people)</p><ul><li>There can be changes in the level of certain substances in your blood. This can lead to you feeling unusually tired or short of breath and being more likely&nbsp;to bruise or get an infection.</li><li>Feeling depressed, confused, seeing or hearing unexplained things&nbsp;(hallucinations).</li><li>Headache (sometimes severe).</li><li>Feeling dizzy or having blurred vision.</li><li>Your joints or muscles are painful or swollen or you cannot control their movement.</li><li>Your small blood vessels can become swollen (known as &lsquo;vasculitis&rsquo;). Signs of this can include: a rash, swollen joints or kidney problems.</li><li>Your liver can become swollen. This can lead to: nausea (feeling sick) or&nbsp;vomiting (being sick), loss of appetite or generally feeling unwell, itching,&nbsp;fever, yellowing of the skin and eyes or dark colored urine.</li><li>Flushing or marks on your skin that look like targets.</li><li>Unexplained hair loss.</li><li>Diarrhea.</li><li>Impotence.</li><li>Breast tenderness and/or breast enlargement.</li><li>Breast discharge.&nbsp;</li></ul><p>If any of the side effects gets serious, or if you notice any side effects not listed&nbsp;in this leaflet, please tell your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <ul><li>Keep out of the reach and sight of children.</li><li>Do not use ROLAN after the expiry date which is stated on the label. The&nbsp;expiry date refers to the last day of that month.</li><li>Store below 30&deg; C, protect from light.</li><li>Do not use ROLAN if you notice visible signs of deterioration.</li><li>Medicines should not be disposed of via household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures&nbsp;will help to protect the environment.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance in each 2 ml ampoule is 50 mg ranitidine (as&nbsp;hydrochloride).<br />The other ingredients are phenol, dibasic sodium phosphate, potassium dihydrogen phosphate and distilled water.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                ROLAN solution is clear colorless to pale yellow liquid, practically free from particles. You shouldn’t be able to see any particles in it. It is packaged in type 1
glass ampoule. Each pack contains 5 ampoules.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorization Holder</strong><br />Hikma Pharmaceuticals<br />Bayader Wadi El Seer<br />Industrial Area<br />P.O Box 182400<br />Amman 11118, Jordan<br />Tel: +962 6 580 2900<br />Fax: +962 6 581 7102<br />Website: www.Hikma.com<br /><strong>Manufacturer</strong><br />Hikma Farmaceutica - Portugal<br />(Estrada do Rio Da M6, n.0 8,<br />SA e SB- Fervenca- Sintra)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last approved in 04/2014; version number v1.1.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p style="direction: rtl;">رولان يحتوي على دواء يسمى رانيتيدين.</p><p style="direction: rtl;">ينتمي هذا الدواء إلى مجموعة الأدوية المضادة لمستقبلات H 2.&nbsp;وهي تعمل على تقليل كمية الحامض فيمعدتك.</p><p style="direction: rtl;">يستخدم رولان لدى البالغين (من ضمنهم كبار السن) من أجل:</p><ul><li style="direction: rtl;">علاج وإيقاف القرحة في المعدة أو في الجزء من الأمعاء الذي تفرغ فيه المعدة (الاثنى عشر).</li><li style="direction: rtl;">منع القرح من النزيف.</li><li style="direction: rtl;">تحسين المشاكل التي يسببها الحامض في المريء أو كثرة الحامض في المعدة. قد يسبب كلاهما الألم أو&nbsp; الانزعاج المعروف أحيانا باسم&nbsp;&laquo;عسر&nbsp;الهضم&raquo; و &laquo;سوء الهضم&raquo; أو &laquo;حرقة الفؤاد&raquo;.</li><li style="direction: rtl;">إيقاف خروج الحامض من المعدة بينما يكون المريض تحت التخدير خلال العمليات الجراحية.</li></ul><p style="direction: rtl;">يستخدم رولان لدى الأطفال (من عمر 6 أشهر إلى 18 سنة) من أجل:</p><ul><li style="direction: rtl;">علاج وإيقاف القرحة في المعدة أوفي الجزء من الأمعاء الذي تفرغ فيه المعدة (الاثنى عشر).</li><li style="direction: rtl;">تحسين المشاكل التي يسببها الحامض في المريء أو كثرة الحامض في المعدة. قد يسبب كلاهما الألم أو&nbsp; الانزعاج المعروف أحيانا باسم&nbsp;&laquo;عسر&nbsp;الهضم&raquo; و &laquo;سوء الهضم&raquo; أو &laquo;حرقة الفؤاد&raquo;.</li></ul>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p style="direction: rtl;"><strong>موانع استعمال رولان:</strong></p><p style="direction: rtl;">&bull;إذا كنت أرجيا (مفرط الحساسية) لرانيتيدين أو لإحدى المواد المستخدمة في تركيبة رولان.</p><p style="direction: rtl;">ينبغي استشارة طبيبك أو الصيدلي قبل استخدام رولان إذا لم تكن متأكدا.</p><p style="direction: rtl;"><strong>الاحتياطات عند استخدام رولان:</strong></p><p style="direction: rtl;">يجب استشارة طبيبك أو الصيدلي قبل استخدام رولان. في الحالات التالية:</p><ul><li style="direction: rtl;">إذا كنت تعاني من سرطان المعدة.</li><li style="direction: rtl;">إذا كنت تعاني من مشاكل في الكلى. فقد تحتاج إلى كمية مختلفة من رولان.</li><li style="direction: rtl;">إذا كنت تعاني سابقا من قرح في المعدة.</li><li style="direction: rtl;">إذا كانت لديك سوابق من اضطرابات القلب.</li><li style="direction: rtl;">إذا كنت تعاني من مرض نادر يسمى البرفيرية الحادة.</li><li style="direction: rtl;">إذا كان عمرك أكثر من 65 عاما.</li><li style="direction: rtl;">إذا كنت تعاني من مرض رئوي.</li><li style="direction: rtl;">إذا كنت تعاني من مرض السكري.</li><li style="direction: rtl;">إذا كنت تعاني من مشاكل في جهازك المناعي.</li></ul><p style="direction: rtl;">إذا لم تكن متأكدا إذا أي من ما ورد أعلاه ينطبق عليك، يجب استشارة طبيبك أو الصيدلي قبل استخدام&nbsp;هذا الدواء.</p><p style="direction: rtl;"><strong>التداخلات الدوائية مع الأدوية الأخرى أو الأعشاب أو المكملات غذائية</strong></p><p style="direction: rtl;">يجب استشارة طبيبك أو الصيدلي إذا كنت تأخذ أو أخذت مؤخراً أية أدوية أخرى، بما في ذلك الأدوية&nbsp;التي تم الحصول عليها بدون وصفة طبية والأدوية العشبية. قد تتأثر هذه الأدوية في رولان أو قد يؤثر</p><p style="direction: rtl;">في حسن أداءها.</p><p style="direction: rtl;">يجب إخبار طبيبك أو الصيدلي بالأخص إذا كنت تأخذ أحد الأدوية التالية:</p><ul><li style="direction: rtl;">ليدوكايين، مخدر موضعي.</li><li style="direction: rtl;">بروبرانولول أو بروكايناميد أو ن-اسيتيل بروكايناميد من أجل معالجة المشاكل القلبية.</li><li style="direction: rtl;">ديازيبام، من أجل معالجة مشاكل الكآبة أو القلق.</li><li style="direction: rtl;">الفينيتوين، من أجل علاج الصرع.</li><li style="direction: rtl;">الثيوفيلين، من أجل علاج المشاكل التنفسية (الربو).</li><li style="direction: rtl;">الوارفارين، من أجل تمييع الدم.</li><li style="direction: rtl;">الغليبيزيد، من أجل خفض نسبة الجلوكوز في الدم.</li><li style="direction: rtl;">اتازنفير أو ديلافيريدين، من أجل علاج الإصابة بفيروس نقص المناعة البشرية.</li><li style="direction: rtl;">تريازولام، من أجل الأرق.</li><li style="direction: rtl;">جفيتينيب، من أجل علاج سرطان الرئة.</li><li style="direction: rtl;">الكيتوكونازول، دواء مضاد للفطريات، يستخدم في بعض الأحيان من أجل علاج مرض السلاق.</li></ul><p style="direction: rtl;">ميدازولام هو دواء قد يعطى إليك مباشرة قبل العملية الجراحية. أخبر طبيبك أنك تأخذ رولان قبل العملية في&nbsp;حالة أنه أو أنها تريد إعطائك ميدازولام.</p><p style="direction: rtl;">إذا لم تكن متأكدا إذا أي من ما ورد أعلاه ينطبق عليك، يجب استشارة طبيبك أو الصيدلي قبل استخدام رولان.</p><p style="direction: rtl;"><strong>الحمل والرضاعة</strong></p><p style="direction: rtl;">يجب عدم تناول هذا الدواء إذا كنت حاملاً أو مرضعة، أو تعتقدين أنك حاملاً إلا إذا قرر طبيبك بأنه ضروري.</p><p style="direction: rtl;">يرجى استشارة طبيبك أو الصيدلي قبل تناول أي دواء إذا كنت حاملاً أو مرضعة.</p><p style="direction: rtl;">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p style="direction: rtl;">-ليس من المتوقع على الإطلاق أن تقوم بإعطاء نفسك هذا الدواء. يتم إعطاءه إليك دائما من قبل شخص مدرب على فعل ذلك.</p><p style="direction: rtl;">سوف يتم إعطائك أمبولة رولان إما:</p><ul><li style="direction: rtl;">على شكل حقنة واحدة في العضل.</li><li style="direction: rtl;">على شكل تسريب بطيء في الوريد. حيث يتم إعطائك هذا الدواء ببطء على مدى بضعة دقائق.</li><li style="direction: rtl;">على شكل تسريب مستمر في الوريد. حيث يتم إعطائك هذا الدواء ببطء على مدى بضعة ساعات.</li></ul><p style="direction: rtl;">الجرعة المعتادة للبالغين (من ضمنهم كبار السن) والمراهقين (12 سنة فما فوق) هي 50 ملغم كل 6 أو 8 ساعات على شكل حقنة واحدة في العضل.</p><p style="direction: rtl;">ويمكن إعطاءك جرعات مختلفة على شكل تسريب بطيء أو مستمر، اعتمادا على الحالة التي تعالج من أجلها.</p><p style="direction: rtl;">الأطفال والرضع (من 6 أشهر إلى 11 سنة):</p><p style="direction: rtl;">سوف يقوم طبيبك بإعطائك رولان عن طريق الحقن البطيء في الوريد. الجرعة القصوى هي 50 ملغم كل 6 أو&nbsp;8 ساعات. يتم إعطاءها عادة فقط عندما لا يستطيع الطفل تناول رولان عن طريق الفم.</p><p style="direction: rtl;"><strong>الجرعة الزائدة من رولان</strong></p><p style="direction: rtl;">يقوم الطبيب أو الممرض بإعطائك أمبولة رولان، لذلك من غير المفترض أنك سوف تعطى الكثير. إذا كنت تعتقد&nbsp;بأنك تلقيت الكثير أو قد نسيت جرعة، أخبر طبيبك أو الممرض.</p><p style="direction: rtl;"><strong>نسيان تناول جرعة رولان</strong></p><p style="direction: rtl;">من غير المفترض حيث أن رولان قد أعطي إليك من قبل الطبيب أو مقدم الرعاية الصحية. ولكن إذا كنت قلقا&nbsp;بشأن نسيان جرعة، تكلم مع طبيبك أو مقدم الرعاية الصحية.</p><p style="direction: rtl;">للاستفسار أو المزيد من المعلومات عن استخدام هذا الدواء، يرجى استشارة الطبيب أو مقدم الرعاية&nbsp;الصحية أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p style="direction: rtl;">مثل جميع الأدوية، قد يعاني بعض المرضى من أعراض جانبية يسببها رولان.</p><p>&nbsp;</p><div style="direction: rtl;"><span style="text-align:unset">قد تحدث الأعراض الجانبية التالية مع هذا الدواء.</span></div><div style="direction: rtl;"><span style="text-align:unset">توقف عن تناول رولان وراجع طبيبك على الفور إذا لاحظت أي من الأعراض الجانبية الخطيرة التالية، فقد&nbsp;تكون في حاجة إلى علاج طبي عاجل:</span></div><ul><li style="direction: rtl;">ردود فعل تحسسية ويمكن أن تشمل الأعراض:</li></ul><p>&nbsp;</p><div style="direction: rtl;"><span style="text-align:unset">- الطفح الجلدي أو الحكة أو بثور على الجلد.</span></div><div style="direction: rtl;"><span style="text-align:unset">- تورم في وجهك أو شفتيك أو لسانك أو أجزاء أخرى من الجسم.</span></div><div style="direction: rtl;"><span style="text-align:unset">- ألم في الصدر وضيق النفس أو الأزيز أو صعوبة في التنفس.</span></div><div style="direction: rtl;"><span style="text-align:unset">- حمى من دون تفسير والشعور بالإعياء، خاصة عند الوقوف.</span></div><ul><li style="direction: rtl;">مشاكل في الكلى، التي يمكن أن تؤدي إلى ألم في الظهر وحمى وألم عند التبول ودم في البول وتغييرات في فحوصات الدم.</li><li style="direction: rtl;">ألم شديد في المعدة، الذي قد يكون من أعراض شيء يسمى &laquo;التهاب البنكرياس&raquo;.</li><li style="direction: rtl;">بطء أو عدم انتظام ضربات القلب.</li></ul><p>&nbsp;</p><div style="direction: rtl;"><span style="text-align:unset">تأكد من طبيبك في زيارتك المقبلة إذا لاحظت أحد الأعراض التالية:</span></div><div style="direction: rtl;"><strong><strong style="text-align:unset">الغير شائعة</strong><span style="text-align:unset"> (تؤثر في أقل من 1 بين 100 شخص)</span></strong></div><ul><li style="direction: rtl;">ألم في المعدة.</li><li style="direction: rtl;">الإمساك.</li><li style="direction: rtl;">الشعور بالمرض (الغثيان).</li></ul><p style="direction: rtl;"><strong>النادرة</strong> (تؤثر في أقل من 1 بين 1000 شخص)</p><ul><li style="direction: rtl;">الطفح الجلدي.</li></ul><p style="direction: rtl;"><strong>الأعراض الجانبية النادرة التي تظهر في فحوصات الدم:</strong></p><ul><li style="direction: rtl;">زيادة كرياتينين المصل في الدم (فحص وظيفة الكلى).</li><li style="direction: rtl;">تغييرات في وظيفة الكبد.</li></ul><p>&nbsp;</p><div style="direction: rtl;"><span style="text-align:unset">تأكد من طبيبك في أقرب فرصة ممكنة إذا لاحظت أحد الأعراض التالية:</span></div><div style="direction: rtl;"><strong><strong style="text-align:unset">النادرة جدا </strong><span style="text-align:unset">(تؤثر في أقل من 1 بين 10000 شخص)</span></strong></div><ul><li style="direction: rtl;">قد توجد تغييرات في مستويات بعض المواد في دمك. ويمكن أن يؤدي هذا إلى الشعور بالتعب غير المعتاد&nbsp;أو ضيق النفس وتكون احتمالية إصابتك بالكدمات أو الالتهابات أكثر.</li><li style="direction: rtl;">الشعور بالاكتئاب أو الارتباك أو رؤية أو سمع أشياء من دون تفسير (الهلوسة).</li><li style="direction: rtl;">الصداع (أحيانا شديد).</li><li style="direction: rtl;">الشعور بالدوخة أو عدم وضوح الرؤية.</li><li style="direction: rtl;">الألم أو التورم في مفاصلك أو عضلاتك أو عدم السيطرة على حركات أي منهما.</li><li style="direction: rtl;">قد تتورم أوعية الدم الصغيرة لديك (معروف باسم &laquo; التهاب الأوعية الدموية&raquo;). وقد تشمل علاماته: الطفح الجلدي أو تورم المفاصل أو مشاكل في الكلى.</li><li style="direction: rtl;">قد يتورم كبدك. وقد يؤدي هذا إلى: الغثيان (الشعور بالمرض) أو التقيؤ (المرض) وفقدان الشهية أو&nbsp;بصفة عامة عدم الشعور بصحة جيدة والحكة والحمى واصفرار الجلد والعينين أو لون البول الداكن.</li><li style="direction: rtl;">الاحمرار أو علامات على الجلد تشبه الأهداف.</li><li style="direction: rtl;">&bull;تساقط الشعر غير المبرر.</li><li style="direction: rtl;">الإسهال.</li><li style="direction: rtl;">العجز الجنسي.</li><li style="direction: rtl;">ألم في الثدي و / أو تضخم الثدي.</li><li style="direction: rtl;">إفراز الثدي.</li></ul><p style="direction: rtl;">راجع طبيبك أو الصيدلي إذا ساءت أية من هذه الآثار الجانبية أو لاحظت ظهور أية أعراض جانبية غير مدرجة في هذه النشرة.&nbsp; &nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <ul><li style="direction: rtl;">إحفظ هذا الدواء بعيدا عن مرأى ومتناول الأطفال.</li><li style="direction: rtl;">لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المذكور على الملصق. يشير تاريخ الانتهاء إلى اليوم&nbsp;الأخير من ذلك الشهر.</li><li style="direction: rtl;">يحفظ تحت 30 &deg; مئوية، احمه من الضوء.</li><li style="direction: rtl;">لا تستخدم رولان إذا لاحظت علامات تلف واضحة عليه.</li><li style="direction: rtl;">لا تتخلص من الأدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية&nbsp;التخلص من الأدوية التي لم تعد بحاجة إليها. سوف تساعد هذه الإجراءات في حماية البيئة.</li></ul>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p style="direction: rtl;">إن المادة الفعالة في كل أمبولة 2 مل هي 50 ملغم من رانيتيدين (على شكل هايدروكلوريد).</p><p style="direction: rtl;">المواد الأخرى المستخدمة في التركيبة التصنيعية هي الفينول وفوسفات الصوديوم ثنائي القاعدة وفوسفات&nbsp;البوتاسيوم ثنائي الهايدروجين وماء منقى.</p><p style="direction: rtl;">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            محلول رولان هو سائل صافي عديم اللون إلى أصفر باهت وعمليا خال من الجسيمات. ينبغي أن لا تكون قادرا على رؤية أي جسيمات في داخله. يتم تعبئته في أمبولة زجاجية من الفئة 1. تحتوي كل علبة على 5 أمبولات.
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p style="direction: rtl;"><strong>اسم وعنوان مالك رخصة التسويق</strong></p><p style="direction: rtl;">شركة أدوية الحكمة</p><p style="direction: rtl;">بيادر وادي السير، المدينة الصناعية</p><p style="direction: rtl;">صندوق بريد 182400</p><p style="direction: rtl;">عمان 11118 ، الأردن</p><p style="direction: rtl;">هاتف: 96265802900+</p><p style="direction: rtl;">فاكس: 96265817102+</p><p style="direction: rtl;">الموقع الإلكتروني:&nbsp;www.Hikma.com&nbsp;</p><p style="direction: rtl;"><strong>الشركة المصنعة</strong></p><p style="direction: rtl;">شركة حكمة فارماسوتيكا &ndash; البرتغال</p><p style="direction: rtl;">استرادا دو ريو دا م 6 ، ن. 08 ، س ا&nbsp;e&nbsp;س ب</p><p style="direction: rtl;">فيرفينشيا، سنترا</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت الموافقة على هذه النشرة بتاريخ 2014/04؛ رقم النسخة ن1.1.
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Rolan® 50 mg/2 ml Ampoules
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each 2 ml contain 56.0 mg of ranitidine hydrochloride, equivalent to 50 mg ranitidine.

For a full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Clear colorless to faintly yellow solution in clear ampoules.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Adults</u></p><p>Rolan Injection is indicated for the treatment of duodenal ulcer, benign gastric ulcer, post - operative ulcer, reflux oesophagitis, Zollinger - Ellison Syndrome and the following conditions where reduction of gastric secretion and acid output is desirable:</p><p>The prophylaxis of gastrointestinal haemorrhage from stress ulceration in seriously ill patients, the prophylaxis of recurrent haemorrhage in patients with bleeding peptic ulcers and before general anaesthesia in patients considered to be at risk of acid aspiration (Mendelson&#39;s Syndrome), particularly obstetric patients during labour.</p><p>&nbsp;</p><p><u>Children (6 months to 18 years)</u></p><p>Rolan Injection is indicated for the short term treatment of peptic ulcer and the treatment of gastro-oesophageal reflux, including reflux oesophagitis and symptomatic relief of gastro-oesophageal reflux disease.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>(See Section 5.2 Pharmacokinetic Properties-Special patient population)</p><p>&nbsp;</p><p><u>Adults (including elderly) / Adolescents (12 years and over)</u></p><p>Rolan Injection may be given either as a slow (over 2 minutes) intravenous injection up to a maximum of 50 mg, after dilution to a volume of 20 ml per 50 mg dose, which may be repeated every 6 to 8 hours; or as an intermittent intravenous infusion at a rate of 25 mg per hour for two hours; the infusion may be repeated at 6 to 8 hour intervals, or as an intramuscular injection of 50 mg (2 ml) every 6 to 8 hours.</p><p>&nbsp;</p><p>Prophylaxis of haemorrhage from stress ulceration or recurrent haemorrhage:</p><p>In the prophylaxis of haemorrhage from stress ulceration in seriously ill patients or the prophylaxis of recurrent haemorrhage in patients bleeding from peptic ulceration, parenteral administration may be continued until oral feeding commences. Patients considered to be still at risk may then be treated with Rolan tablets 150 mg twice daily.</p><p>&nbsp;</p><p>In the prophylaxis of upper gastro-intestinal haemorrhage from stress ulceration in seriously ill patients a priming dose of 50 mg as a slow intravenous injection followed by a continuous intravenous infusion of 0.125 - 0.250 mg/kg/hr may be preferred.</p><p>&nbsp;</p><p>Prophylaxis of Mendleson&#39;s syndrome:</p><p>In patients considered to be at risk of developing acid aspiration syndrome, Rolan Injection 50 mg may be given intramuscularly or by slow intravenous injection 45 to 60 minutes before induction of general anaesthesia.</p><p>&nbsp;</p><p><u>Children / Infants (6 months to 11 years)</u></p><p>(See Section 5.2 Pharmacokinetic Properties) &ndash; Special Patient Populations</p><p>&nbsp;</p><p>Rolan injection may be given as a slow (over 2 minutes) i.v. injection up to a maximum of 50 mg every 6 to 8 hours.</p><p>&nbsp;</p><p><u>Peptic Ulcer Acute Treatment and Gastro-Oesophageal Reflux</u></p><p>Intravenous therapy in children with peptic ulcer disease is indicated only when oral therapy is not possible.</p><p>&nbsp;</p><p>For acute treatment of peptic ulcer disease and gastro-oesophageal reflux in paediatric patients, Rolan injection may be administered at doses that have been shown to be effective for these diseases in adults and effective for acid suppression in critically ill children. The initial dose (2.0 mg/kg or 2.5 mg/kg, maximum 50 mg) may be administered as a slow intravenous infusion over 10 minutes, either with a syringe pump followed by a 3 mL flush with normal saline over 5 min, or following dilution with normal saline to 20 mL. Maintenance of pH &gt; 4.0 can be achieved by intermittent infusion of 1.5 mg/kg every 6 h to 8 h. Alternatively treatment can be continuous, administering a loading dose of 0.45 mg/kg followed by a continuous infusion of 0.15 mg/kg/hr.</p><p>&nbsp;</p><p><u>N</u><u>eonates (under 1 month)</u></p><p>(See Section 5.2 &ndash; Pharmacokinetic Properties &ndash; Special Patient Populations)</p><p>&nbsp;</p><p><u>Patients over 50 years of age</u></p><p>See Section 5.2 Pharmacokinetic Properties (Special Patient Populations, Patients over&nbsp;50 years of age)</p><p>&nbsp;</p><p><u>Renal Impairment</u></p><p>Accumulation of ranitidine with resulting elevated plasma concentrations will occur in patients with renal impairment (creatinine clearance less than 50 ml/min). Accordingly, it is recommended in such patients that ranitidine be administered in doses of 25 mg.</p><p>&nbsp;</p><p><u>Route of Administration</u></p><p>Intravenous or intramuscular injection</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Ranitidine is contraindicated for patients known to have hypersensitivity to any component of the preparation.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Treatment with a histamine H<sub>2</sub>-antagonist may mask symptoms associated with carcinoma of the stomach and may therefore delay diagnosis of the condition. Accordingly, where gastric ulcer is suspected, the possibility of malignancy should be excluded before therapy with Rolan is instituted.</p><p>&nbsp;</p><p>Ranitidine is excreted via the kidney. Therefore plasma levels of the drug are increased in patients with renal impairment. The dosage should be adjusted as detailed in section 4.2 in Renal Impairment.</p><p>&nbsp;</p><p>Bradycardia in association with rapid administration of ranitidine injection has been reported rarely, usually in patients with factors predisposing to cardiac rhythm disturbances. Recommended rates of administration should not be exceeded.</p><p>&nbsp;</p><p>It has been reported that the use of higher than recommended doses of intravenous H<sub>2</sub>- antagonists has been associated with rises in liver enzymes when treatment has been extended beyond five days.</p><p>&nbsp;</p><p>Although clinical reports of acute intermittent porphyria associated with ranitidine administration have been rare and inconclusive, ranitidine should be avoided in patients with a history of this condition.</p><p>&nbsp;</p><p>In patients such as the elderly, persons with chronic lung disease, diabetes or the immunocompromised, &nbsp;there &nbsp;may &nbsp;be &nbsp;an &nbsp;increased &nbsp;risk &nbsp;of &nbsp;developing &nbsp;community acquired pneumonia. A large epidemiological study showed an increased risk of developing community acquired pneumonia in current users of ranitidine alone versus those who had stopped treatment, with an observed adjusted relative risk increase of&nbsp;1.82 &nbsp;(95% &nbsp;CI &nbsp;1.26-2.64). &nbsp;Postmarketing &nbsp;data &nbsp;indicate &nbsp;reversible &nbsp;mental &nbsp;confusion, depression, and hallucinations have been reported most frequently in severely ill and elderly patients (see section 4.8).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ranitidine has the potential to affect the absorption, metabolism or renal excretion of other drugs. The altered pharmacokinetics may necessitate dosage adjustment of the affected drug or discontinuation of treatment.</p><p>&nbsp;</p><p>Interactions occur by several mechanisms including:</p><p>Inhibition of cytochrome P450-linked mixed function oxygenase system: Ranitidine at usual therapeutic doses does not potentiate the actions of drugs which are inactivated by this enzyme system such as diazepam, lidocaine, phenytoin, propanolol and theophylline.</p><p>&nbsp;</p><p>There have been reports of altered prothrombin time with coumarin anticoagulants (e.g. warfarin). Due to the narrow therapeutic index, close monitoring of increased or decreased prothrombin time is recommended during concurrent treatment with ranitidine.</p><p>&nbsp;</p><p>Competition for renal tubular secrection:</p><p>Since ranitidine is partially eliminated by the cationic system, it may affect the clearance of other drugs eliminated by this route. High doses of ranitidine (e.g. such as those used&nbsp;in the treatment of Zollinger-Ellison syndrome) may reduce the excretion of procainamide and N-acetylprocainamide resulting in increased plasma level of these drugs.</p><p>&nbsp;</p><p>Alteration of gastric pH:</p><p>The bioavailability of certain drugs may be affected. This can result in either an increase in absorption (e.g. triazolam, midazolam, glipizide) or a decrease in absorption (e.g. ketoconazole, atazanavir, delaviridine, gefitnib).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy Category B.</p><p>Ranitidine crosses the placenta but therapeutic doses administered to obstetric patients in labour or undergoing caesarean section have been without any adverse effect on labour, delivery or subsequent neonatal progress. Ranitidine is also excreted in human breast milk. Like other drugs, Rolan should only be used during pregnancy and nursing if considered essential.</p><p>&nbsp;</p><p>There are no data on the effects of ranitidine on human fertility. There were no effects on male and female fertility in animal studies.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None Known.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following convention has been utilised for the classification of undesirable effects: very common (&ge;1/10), common (&ge;1/100, &lt;1/10), uncommon (&ge;1/1000, &le;1/100), rare (&ge;1/10,000, &le;1/1000), very rare (&le;1/10,000). Adverse event frequencies have been estimated from spontaneous reports from post-marketing data.</p><p>&nbsp;</p><p><strong>Blood &amp; Lymphatic System Disorders</strong></p><p>Very Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Blood count changes (leucopenia, thrombocytopenia). These are usually reversible. Agranulocytosis or pancytopenia, sometimes with marrow hypoplasia or&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; marrow aplasia.</p><p>&nbsp;</p><p><strong>I</strong><strong>mm</strong><strong>un</strong><strong>e System Disorders</strong></p><p>Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hypersensitivity reactions (urticaria, angioneurotic oedema, fever, bronchospasm, hypotension and chest pain).</p><p>Very Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Anaphylactic shock.</p><p>&nbsp;</p><p>These events have been reported after a single dose.</p><p>&nbsp;</p><p><strong>Psychiatric Disorders</strong></p><p>Very Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reversible mental confusion, depression and hallucinations.</p><p>&nbsp;</p><p>These have been reported predominantly in severely ill and elderly patients.</p><p>&nbsp;</p><p><strong>Nervous System Disorders</strong></p><p>Very Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Headache (sometimes severe), dizziness.and reversible involuntary movement disorders.</p><p>&nbsp;</p><p><strong>Eye Disorders</strong></p><p>Very Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reversible blurred vision.</p><p>&nbsp;</p><p>There have been reports of blurred vision, which is suggestive of a change in accommodation.</p><p>&nbsp;</p><p><strong>Cardiac Disorders</strong></p><p>Very Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; As with other H2 receptor antagonists bradycardia, A-V Block and asystole.</p><p>&nbsp;</p><p><strong>Vascular Disorders</strong></p><p>Very Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vasculitis.</p><p>&nbsp;</p><p><strong>Gastrointestinal Disorders</strong></p><p>Uncommon:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Abdominal pain, constipation, nausea (these symptoms mostly improved during continued treatment).</p><p>Very Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Acute pancreatitis, diarrhoea.</p><p>&nbsp;</p><p><strong>Hepatobiliary Disorders</strong></p><p>Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transient and reversible changes in liver function tests.</p><p>Very Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hepatitis (hepatocellular, hepatocanalicular or mixed) with or without jaundice, these were usually reversible.</p><p>&nbsp;</p><p><strong>Skin and Subcutaneous Tissue Disorders</strong></p><p>Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Skin Rash.</p><p>Very Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Erythema multiforme, alopecia.</p><p>&nbsp;</p><p><strong>M</strong><strong>u</strong><strong>sculoskeletal and Connective Tissue Disorders</strong></p><p>Very Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Musculoskeletal symptoms such as arthralgia and myalgia.</p><p>&nbsp;</p><p><strong>Re</strong><strong>n</strong><strong>a</strong><strong>l and Urinary Disorders</strong></p><p>Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Elevation of plasma creatinine (usually slight; normalised during continued treatment)</p><p>Very Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Acute interstitial nephritis.</p><p>&nbsp;</p><p><strong>Re</strong><strong>pr</strong><strong>oductive System and Breast Disorders</strong></p><p>Very Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reversible impotence,breast symptoms and breast conditions (such as gynaecomastia and galactorrhoea).</p><p>&nbsp;</p><p>The safety of ranitidine has been assessed in children aged 0 to 16 years with acid- related disease and was generally well tolerated with an adverse event profile resembling that in adults. There are limited long term safety data available, in particular regarding growth and development.</p><p>&nbsp;</p><p><u>Reporting of suspected adverse reactions</u></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Saudi Arabia:</p><p>The National Pharmacovigilance and Drug Safety Centre (NPC)</p><p>Fax: +966-11-205-7662</p><p>Toll free: 800-249-0000</p><p>Phone No.: +966-11-2038222, Exts: 2317-2334-2340-2353-2354-2356.</p><p>Email: npc.drug@sfda.gov.sa</p><p>Website: www.sfda.gov.sa/npc</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp; &nbsp;Other GCC States:</p><p>Please contact the relevant competent authority</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Rolan is very specific in action and accordingly, no particular problems are expected following overdosage with the drug. Symptomatic and supportive therapy should be given as appropriate.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: H2-receptor antagonists.</p><p>ATC code: A02BA02</p><p>&nbsp;</p><p>Ranitidine is a specific, rapidly acting histamine H2-antagonist. It inhibits basal and stimulated secretion of gastric acid, reducing both the volume and the acid and pepsin content of the secretion.</p><p>&nbsp;</p><p>The clinical data available mentions the use of ranitidine in children to prevent stress ulcers. No direct evidence for prevention of stress ulcers is available. Treatment for these patients is based on the observation that pH is above 4 after administration of ranitidine. The value of this surrogate parameter in children with stress ulcers remains to be established.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Absorption</u></p><p>Absorption of ranitidine after intramuscular injection is rapid and peak plasma concentrations are usually achieved within 15 minutes of administration.</p><p>&nbsp;</p><p><u>M</u><u>etabolism</u></p><p>Ranitidine is not extensively metabolised. The fraction of the dose recovered as metabolites is similar after both oral and i.v. dosing; and includes 6% of the dose in urine as the N-oxide, 2% as the S-oxide, 2% as&nbsp; desmethylranitidine and 1 to 2% as the furoic acid analogue.</p><p>&nbsp;</p><p><u>Elimination</u></p><p>Plasma concentrations decline bi-exponentially, with a terminal half-life of 2-3 hours. The major route of elimination is renal. After IV administration of 150 mg 3H-ranitidine,&nbsp;98% of the dose was recovered, including 5% in faeces and 93% in urine, of which 70% was unchanged parent drug. After oral administration of 150 mg 3H-ranitidine, 96% of the dose was recovered, 26% in faeces and 70% in urine of which 35% was unchanged parent drug. Less than 3% of the dose is excreted in bile. Renal clearance is approximately 500 mL/min, which exceeds glomerular filtration indicating net renal tubular secretion.</p><p>&nbsp;</p><p>Special Patient Populations</p><p><em>Children/infants (6 months and above)</em></p><p>Limited pharmacokinetic data show that there were no significant differences in half-life (range for children 3 years and above: 1.7 - 2.2 h) and plasma clearance (range for children 3 years and above: 9 - 22 ml/min/kg) between children and healthy adults receiving intravenous ranitidine when correction is made for body weight. Pharmacokinetic data in infants is extremely limited but appears to be in line with that for older children.</p><p>&nbsp;</p><p><em>Patients over 50 years of age</em></p><p>In patients over 50 years of age, half-life is prolonged (3-4 h) and clearance is reduced, consistent with the age-related decline of renal function. However, systemic exposure and accumulation are 50% higher. This difference exceeds the effect of declining renal function, and indicates increased bioavailability in older patients.</p><p>&nbsp;</p><p><em>N</em><em>eonates (under 1 month)</em></p><p>Limited pharmacokinetic data from term babies undergoing treatment with Extracorporeal&nbsp;&nbsp; Membrane&nbsp; &nbsp;Oxygenation&nbsp; &nbsp;(EMCO)&nbsp; &nbsp;suggests&nbsp; &nbsp;that&nbsp; &nbsp;plasma&nbsp; &nbsp;clearance following iv administration may be reduced (1.5-8.2 ml/min/kg) and the half-life increased in the new-born. Clearance of ranitidine appeared to be related to the estimated glomerular filtration rate in the neonates.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Non-clinical data revealed no special hazard for humans based on conventional studies of safety pharmacology, repeated-dose toxicity, genotoxicity, carcinogenic potential and toxicity to reproduction and development.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>- Phenol</p><p>- Dibasic sodium phosphate</p><p>- Potassium dihydrogen phosphate</p><p>- Distilled water</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>See section 6.6 for Use/Handling.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months.

Shelf life after dilution:
It is recommended that the solutions should be prepared right before use and administered  right  after  its  preparation.  If  any  particular  circumstances  force  the storage of the diluted solutions before use, it is recommended to be up to 24 hours at room  temperature  for  diluted  solutions  since  there  are  not  available  data  for  the behavior of the product after this storage period.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C, protect from light.</p><p>&nbsp;</p><p>Rolan solution should not be autoclaved.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>2 ml Type 1 glass ampoules.</p><p>&nbsp;</p><p>Pack of 5 ampoules.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Rolan injection has been shown to be compatible with the following infusion fluids:</p><p>- 0.9% Sodium Chloride BP</p><p>- 5% Dextrose BP</p><p>- 0.18% Sodium Chloride and 5% Dextrose BP</p><p>- 4% Sodium Bicarbonate BP</p><p>- Hartmann&rsquo;s solution (Ringer&rsquo;s lactate)</p><p>All unused mixtures of Rolan injection with infusion fluids should not be used after 24 hours of preparation.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hikma Pharmaceuticals
Bayader Wadi El Seer
Industrial Area
P.O Box 182400
Amman 11118, Jordan
Tel: (962-6)5802900
Fax: (962-6) 5817102

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                29 September 2015
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>